Live
FierceBiotechFDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trialFierceBiotechVoyager pauses Alzheimer's program just 8 months after unveiling assetFierceBiotechRepublican senator slams FDA rare disease rebuffs, pledges to investigate recent actions: BloombergFierceBiotechFDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejectionEndpoints NewsVertex reports Phase 3 win for kidney drug, will seek FDA approvalEndpoints NewsAscletis touts GLP-1 quarterly dosing data; Mineralys apnea Phase 2 missesBioPharma DiveXenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapyEndpoints NewsWatch: Who won the Hims vs. Novo feud?Promega BlogWhy BRETSA™ Target Engagement Matters for Drug DiscoveryEndpoints NewsChina is going after the world's most expensive drugs: Endpoints SignalEndpoints NewsFDA widens use of leucovorin without new trial dataBioWorldShionogi patents new agents for HIV-1 infection
Endpoints News Mar 10, 2026

FDA widens use of leucovorin without new trial data

FDA widens use of leucovorin without new trial data

Original
Body unavailable. Use the original source.

Directory

59 All